The goal of HATIP is to consider how appropriate and effective treatment, including but not limited to antiretroviral (ARV) drugs, can become a practical reality in settings with few resources. Each newsletter will contain specialist comment from doctors with expertise in delivering ARVS and AIDS treatment in resource-limited settings. Julian Meldrum, the editor, says HATIP recognizes that "for medicines to be effective in the real world, other things are important besides the supply of drugs, including the relationships between treatment providers and people with HIV as well as wider patterns of support and care within families and communities."
Each edition will review one major topic in HIV and AIDS treatment. The first issue features a review of the place of co-trimoxazole prophylaxis (CTX) in expanding treatment for people with HIV. It asks who could benefit from CTX prophylaxis and sets out some issues for individuals and communities in supporting CTX use. It looks at issues raised where CTX is promoted in the absence of access to ARV and finally at how it might be used to support the introduction of ARVs when these become available. The article includes commentary from Dr. Vijay Anthony Prabhu (India), Dr. Adama Ndir (Senegal), Dr. Leon Regensberg, Dr. Douglas Wilson (South Africa), Molly Tumusiime (Uganda) and Prof. Brian Gazzard (UK).
You can subscribe to the newsletter by visiting www.aidsmap.com or by sending an e-mail with your name, e-mail address and the country in which you work to: firstname.lastname@example.org with the words "add HATIP list" in the subject line.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.